Plasmodium falciparum in Aotus nancymaae: A New Model for Placental Malaria.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
26 08 2022
Historique:
received: 28 01 2022
accepted: 11 03 2022
pubmed: 16 3 2022
medline: 31 8 2022
entrez: 15 3 2022
Statut: ppublish

Résumé

Plasmodium falciparum-infected erythrocytes that display the variant surface antigen VAR2CSA bind chondroitin sulfate A (CSA) to sequester in placental intervillous spaces, causing severe sequelae for mother and offspring. Here, we establish a placental malaria (PM) monkey model. Pregnant Aotus infected with CSA-binding P. falciparum CS2 parasites during the third trimester developed pronounced sequestration of late-stage parasites in placental intervillous spaces that express VAR2CSA and bind specifically to CSA. Similar to immune multigravid women, a monkey infected with P. falciparum CS2 parasites over successive pregnancies acquired antibodies against VAR2CSA, with potent functional activity that was boosted upon subsequent pregnancy infections. Aotus also developed functional antibodies after multiple acute PM episodes and subsequent VAR2CSA immunization. In summary, P. falciparum infections in pregnant Aotus monkeys recapitulate all the prominent features of human PM infection and immunity, and this model can be useful for basic mechanistic studies and preclinical studies to qualify candidate PM vaccines. Clinical Trials Registration: NCT02471378.

Identifiants

pubmed: 35290467
pii: 6549045
doi: 10.1093/infdis/jiac096
pmc: PMC9417121
doi:

Substances chimiques

Antibodies, Protozoan 0
Antigens, Protozoan 0
Chondroitin Sulfates 9007-28-7

Banques de données

ClinicalTrials.gov
['NCT02471378']

Types de publication

Clinical Study Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-527

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2022.

Références

Malar J. 2015 Mar 18;14:118
pubmed: 25889709
Lancet Infect Dis. 2007 Feb;7(2):105-17
pubmed: 17251081
Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):158-73
pubmed: 11388509
Lancet. 2020 Mar 7;395(10226):779
pubmed: 32145785
Nature. 1998 Oct 29;395(6705):851-2
pubmed: 9804416
Science. 1996 Jun 7;272(5267):1502-4
pubmed: 8633247
Mol Microbiol. 2003 Jul;49(1):179-91
pubmed: 12823820
Sci Rep. 2017 Oct 24;7(1):13872
pubmed: 29066816
Malar J. 2019 Apr 11;18(1):128
pubmed: 30971252
Lab Anim (NY). 2017 Oct 6;46(10):388-398
pubmed: 28984865
Infect Immun. 2016 May 24;84(6):1761-1774
pubmed: 27045035
Curr Top Microbiol Immunol. 2005;295:169-200
pubmed: 16265891
Am J Trop Med Hyg. 1969 Nov;18(6):860-5
pubmed: 4982221
J Infect Dis. 2001 Sep 1;184(5):618-26
pubmed: 11494167
Front Immunol. 2021 Mar 15;12:621382
pubmed: 33790894
PLoS One. 2016 Jul 28;11(7):e0160120
pubmed: 27467392
Mediterr J Hematol Infect Dis. 2013;5(1):e2013010
pubmed: 23350023
Am J Trop Med Hyg. 2017 Mar;96(3):642-644
pubmed: 28044045
Cold Spring Harb Perspect Med. 2017 Jun 1;7(6):
pubmed: 28213434

Auteurs

Ankur Sharma (A)

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Bethany Jenkins (B)

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Adovi Akue (A)

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Lynn E Lambert (LE)

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Sachy Orr-Gonzalez (S)

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Marvin L Thomas (ML)

Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, Maryland, USA.

Almahamoudou Mahamar (A)

Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.

Bacary S Diarra (BS)

Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.

Alassane Dicko (A)

Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.

Michal Fried (M)

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Patrick E Duffy (PE)

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH